Brian Hubbard

No open positions remaining

53 year

Consumer Services

Health Technology

Profile

Brian Hubbard worked at Dogma Therapeutics, Inc. from 2015 to 2021 as President, CEO, Secretary, Treasurer & Director.
From 2018 to 2024, Dr. Hubbard was Chief Executive Officer at Anji Pharmaceuticals, Inc. Dr. Hubbard also worked at Metsera, Inc. as Chief Scientific Officer from 2023 to 2025.
Dr. Hubbard completed undergraduate studies at The College of William & Mary and earned a doctorate from the University of Illinois.

Former positions of Brian Hubbard

Companies	Position	End
Anji Pharmaceuticals, Inc. Anji Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of medicines for human genetics	Chief Executive Officer	2024-03-31
Dogma Therapeutics, Inc. Dogma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease	Chief Executive Officer	2021-10-31

See the detail of Brian Hubbard's experience

Training of Brian Hubbard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brian Hubbard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
The College of William & Mary The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Illinois University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Anji Pharmaceuticals, Inc. Anji Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of medicines for human genetics	Health Technology
Dogma Therapeutics, Inc. Dogma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease	Health Technology